Skip to main content

Advertisement

  • Original research
  • Open Access

An untapped potential for imaging of peripheral osteomyelitis in paediatrics using [18F]FDG PET/CT —the inference from a juvenile porcine model

EJNMMI Research20199:29

https://doi.org/10.1186/s13550-019-0498-5

  • Received: 22 November 2018
  • Accepted: 11 March 2019
  • Published:

Abstract

Purpose

To examine parameters affecting the detection of osteomyelitis (OM) by [18F]FDG PET/CT and to reduce tracer activity in a pig model.

Background

[18F]FDG PET/CT is recommended for the diagnosis of OM in the axial skeleton of adults. In children, OM has a tendency to become chronic or recurrent, especially in low-income countries. Early diagnosis and initiation of therapy are therefore essential. We have previously demonstrated that [18F]FDG PET/CT is promising in juvenile Staphylococcus aureus (S. aureus) OM of peripheral bones in a pig model, not failing even small lesions. When using imaging in children, radiation exposure should be balanced against fast diagnostics in the individual case.

Methods

Twenty juvenile pigs were inoculated with S. aureus. One week after inoculation, the pigs were [18F]FDG PET/CT scanned. PET list-mode acquired data of a subgroup were retrospectively processed in order to simulate and examine the image quality obtainable with an injected activity of 132 MBq, 44 MBq, 13.2 MBq, and 4.4 MBq, respectively.

Results

All lesions were detected by [18F]FDG PET and CT. Some lesions were very small (0.01 cm3), and others were larger (4.18 cm3). SUVmax was higher when sequesters (p = 0.023) and fistulas were formed (p < 0.0001). The simulated data demonstrated that it was possible to reduce the activity to 4.4 MBq without compromising image quality in pigs.

Conclusions

[18F]FDG PET/CT localized even small OM lesions in peripheral bones. It was possible to reduce the injected activity considerably without compromising image quality, impacting the applicability of PET/CT in peripheral OM in children.

Keywords

  • Osteomyelitis
  • [18F]FDG PET/CT
  • Dose reduction
  • Children
  • Juvenile pigs
  • Staphylococcus aureus

Background

Osteomyelitis (OM) of long bones may be difficult to treat despite advances in operative techniques and treatment with antibiotics, resulting in considerable morbidity, cost, and sometimes even mortality. The latter is, however, more likely a problem in low-income countries [1, 2]. Cure rates of more than 95% are otherwise achievable with prompt and sufficient treatment [3]. OM has a tendency to become chronic or recurrent. Early diagnosis and initiation of therapy are, therefore, essential to prevent disease progression and to reduce potentially serious complications [4].

The golden standard for diagnosing OM is invasive demanding bone biopsy with histopathologic examination and culturing of the bacteria causing the disease. Imaging on the contrary is non-invasive.

Radiography, computed tomography (CT), and magnetic resonance imaging (MRI) have the advantages of very good spatial resolutions and can show very accurate images of the morphology of anatomical structures. The diagnostic methods using radioisotopes (gamma-camera imaging and positron emission tomography (PET)) have the advantages of showing physiology in vivo, as reflected by the uptake of tracers in the body. Therefore, the techniques are not in competition with each other but complement each other, and by combining modalities like PET and CT, it is possible to acquire both the physiological and the morphological information.

Conventional radiography is unable to diagnose acute OM. OM lesions must extend at least 1 cm and lead to a 30–50% reduction of bone mineral content to generate recognizable radiographic changes [5]. Early findings may be subtle, and changes may not be obvious within the first 5–7 days in children and within 10–14 days in adults. MRI, bone scintigraphy, and CT are central imaging modalities for diagnosing acute OM in children [6], the latter two, however, adding substantially to the radiation exposure of the child. MRI is often considered the best imaging method but is not always available and requires anaesthesia in young children.

Bone scintigraphy demonstrates osteoblastic activity and is considered highly sensitive but not particularly specific [79]; however, the reports on the latter diverge, probably depending on the stage of the disease and the age of the patient as well [10]. [18F]-fluorodeoxyglucose (FDG) PET may have the highest diagnostic accuracy for confirming or excluding chronic OM in comparison with bone scintigraphy, MRI, and leukocyte scintigraphy. [18F]FDG is a glucose analogue containing the radioactive isotope fluorine-18 (18F) and is like glucose taken up by inflammatory cells. Most studies have addressed [18F]FDG PET for use in the axial skeleton [11, 12], and not in the appendicular skeleton. PET/CT is an invaluable diagnostic tool using ionizing radiation. It is important to be aware of the potential risks of radiation-induced cancer associated with PET/CT examinations and to avoid unwarranted examinations. There is a strong urge to use PET/CT where there is a relevant clinical problem, where the outcome depends on the PET/CT examination, and where non-ionizing alternatives such as MRI and ultrasonic sound examination are inferior.

Children are more sensitive to ionizing radiation than adults [13]. Their cells divide more often, and they live longer after irradiation exposure, allowing potential cancers more time to develop. This consideration has been incorporated into the modern health care system, where all procedures in children involving ionizing radiation exposure are in particular optimized to reduce the dose burden. Most procedures are classical X-ray examinations; however, more advanced examinations like CT and PET are playing an increasing role and are contributing more and more to the overall dose derived from medical procedures. When using imaging modalities in children, radiation exposure should therefore be balanced against the possibility of offering a swift and useful diagnostic procedure, which will depend on the individual case.

We have recently demonstrated that [18F]FDG PET was effective in visualizing OM lesions in the peripheral bones of juvenile pigs [1416]. We also saw that both sequesters and fistulas formed as early as during the first week after inoculation with Staphylococcus aureus (S. aureus), indicating an unfavourable stage of OM according to the human Cierny-Mader staging [1719].

OM is most often found in children and elderly [10]. It can be caused by a number of bacteria, but the majority of OM infections are caused by S. aureus [4].

In this study, we focus primarily on ionizing radiation originating from 18F in a juvenile porcine S. aureus OM model, and we simulated different signal-to-noise (SNR) levels in PET images corresponding to various amounts of administered [18F]FDG activity. We hypothesize that very low activity levels of injected [18F]FDG are sufficient to diagnose OM. If the hypothesis is confirmed, this information is useful for protocol optimization in order to reduce the radiation exposure without compromising the diagnostic value.

Material and methods

Pigs and the S. aureus model

Twenty clinically healthy, specific pathogen-free Danish Landrace-Yorkshire crossbreed female pigs aged 8–12 weeks were purchased from local commercial pig farmers. After 1 week of acclimatization, the pigs were, under propofol anaesthesia, inoculated with a suspension of a porcine strain of S. aureus (S54F9) (104–105 colony forming units (CFU) per kilogram body weight (BW) in 1.0 to 1.5 mL saline) into the femoral artery of the right hind limb simulating haematogenously spread OM in children and avoiding reactive changes induced by the trauma of directly inoculating in a peripheral bone, as described [20].

Most pigs developed clinical signs of infection, e.g., limp in the right hind limb, and after the first pigs, the following were supplied with a single intramuscular (i.m.) injection of procaine benzylpenicillin 10,000 IE/kg (Penovet, Boehringer Ingelheim, Copenhagen, Denmark) to avoid sepsis [21]. Buprenorphine (45 μg/kg Temgesic (Reckitt Benckiser, Berkshire, England)) was given three times daily from the time of inoculation until euthanasia [21]. 1 week after the inoculation, the pigs were anaesthetized and scanned.

After scanning, the pigs were euthanized with pentobarbital (100 mg/kg intravenously) and necropsied, macroscopic lesions noted, and samples collected for histopathology and microbiology. For histopathology, tissues were formalin-fixed for 4 days–30 months, decalcified (bone), dehydrated, embedded with paraffin wax, cut in 3–5 μm thick sections, and stained with haematoxylin-eosin (HE) using standard methods.

The study was approved by the Danish Animal Experimentation Board (no. 2012-15-2934-000123 and no. 2017-15-0201-01239). All facilities were approved by the Danish Occupational Health Surveillance.

PET/CT scan

The pigs were CT scanned to confirm OM developments 1 day prior to [18F]FDG PET/CT scans. [18F]FDG was produced by a standard procedure applying a GE Healthcare MX Tracerlab synthesizer, MX cassettes supplied by Rotem Industries (Arava, Israel), and chemical kits supplied by ABX GmbH (Radeberg, Germany). The radiochemical purity was higher than 99%.

Scanning at the Department of Nuclear Medicine and PET Centre in Aarhus was performed with an integrated PET/CT system (Siemens Biograph TruePoint™ 3737 64 PET/CT, Siemens Healthineers, Erlangen, Germany), one bed position spanning 21 cm in the axial direction. The pigs were anaesthetized with propofol and intubated (for mechanical ventilation) and placed in dorsal recumbency as described in [22]. The pigs were placed in the scanners as symmetrical as possible so that the non-inoculated hind limb (left) could be used for comparison. Initially, a scout view was obtained to ensure body coverage of the inoculated limb (right). A CT scan for attenuation correction of PET data was obtained first. PET images were reconstructed using the iterative TrueX algorithm (Siemens), and CT and PET data were co-registered for image fusion by the system. Total activity of 132 MBq [18F]FDG was injected in a jugular vein of the two pigs used for simulation, corresponding to 6.2 MBq/kg BW; the other pigs received 6 MBq/kg BW. CT scans for characterization and diagnostics were used, especially in the beginning of the study as the radiation burden was not a limitation and we wanted to make sure that no lesion was overlooked (lesions were primarily identified by osteolysis). Later on, we managed to reduce the mAs to 29 corresponding to an effective dose of approximately 0.2 mSv for scanning the legs without any loss of information on OM. We did not explore this further, as the CT part of PET/CT scanners has improved remarkably with respect to dose reduction since our scanners were installed.

At the Nuclear Medicine Department of Aalborg University Hospital, the pigs were placed in dorsal recumbency position and PET/CT scanned applying an integrated system (GE VCT Discovery True 64 PET/CT 2006, GE Healthcare, USA), one bed position spanning 15 cm. PET images were reconstructed using an iterative algorithm (ViewPoint algorithm (GE Healthcare)) and attenuation correction based on low-dose CT.

[18F]FDG dose simulation

For two pigs (#12 and #13), PET images from Aarhus were retrospectively simulated from the originally acquired data. PET list-mode data of the hind limbs acquired 30–60 min after injection of [18F]FDG were histogrammed into 60 time frames each with 0.5 min duration and subsequently reconstructed using the TrueX iterative algorithm. Four sets of PET images with a varying signal-to-noise level were generated by summing 2, 6, 20, and 60 time frames symmetrically around the time point 45 min after tracer injection. Thereby, the four sets of images represented 1, 3, 10, and 30 min effective scan time at an average time point of 45 min post-tracer injection. For a constant scan time of 30 min, these images would represent the image quality obtainable with an injected activity of 132 MBq, 44 MBq, 13.2 MBq, and 4.4 MBq respectively.

Reading the scans

PET with [18F]FDG and CT were read individually. PET was also read as fused images with CT. All scans were evaluated by an experienced specialist in nuclear medicine and CT on a Dell Precision T7400 working station (Dell, Austin, TX, USA) using the Philips Extended Brilliance™ Workspace V.4.52.40140 EBW-NM 2.01 software (Philips Health care, PC Best, The Netherlands).

Microbiology

The inoculums were prepared from the S54F9 strain of S. aureus, isolated from a chronic embolic pulmonary abscess in a pig [23]. The strain is pan-susceptible, and the clinical signs of OM were modifiable with procaine benzylpenicillin. The target inoculum was 104 CFU/kg BW and was inoculated in the femoral artery of the right hind limb 7 days prior to the scans. Swabs and tissue biopsies were obtained postmortem for bacteriological culture to confirm the bacterial agent, although S. aureus was identified in a few lesions by immunohistochemistry as described previously [24].

Statistics

A two-tailed Pearson test was used for correlations, and for comparison of groups, a Mann-Whitney U test was used. A p level of < 0.05 was considered statistically significant.

Results

After the inoculation with S. aureus, the pigs developed 56 OM lesions in different anatomical locations in the field covered by CT. The OM lesions were diagnosed by the presence of the main osteolysis by CT. Most lesions were also identified during necropsy revealing concordance between gross pathology changes and the CT diagnoses (Fig. 1). Microbiology (re-isolation of the inoculated S. aureus bacterium) was performed at least in one lesion from each of the pigs, although S. aureus was identified in a few lesions by immunohistochemistry (Table 1). Tissues were collected for histopathology, and descriptions (subacute OM) have been presented, along with other findings, for some of the pigs in previous papers (see references in Table 1).
Fig. 1
Fig. 1

Mid-sagittal cut through the distal femoral bone of the right hind limb of a pig infected by the inoculation of S. aureus into the femoral artery. Pathological chronic, purulent, sequestering osteomyelitis (S) is seen in the metaphysis with disruption of the growth plate (GP) and affection of the epiphysis (arrows). The lesion has a size (diameter) of approximately 2 cm. The thick peripheral zone of granulation tissue (GT). Pig 4, 14 days after the inoculation

Table 1

Findings by CT, PET, necropsy, and microbiology of the individual pigs. Fifty-five of the OM lesions were found in the right hind limb, and one was found in right humerus

Piga

Number of OM (CT)

Number of OM (PET)

Number of OM (necropsy and/or histology)

Microbial S. aureus

Vol. ranges cm3

SUV ranges g/ml

FDG activity MBq/kg

1a

4

4

3

Yes

0.16–2.54

2.6–4.4

7.48

2a

1

1

1

Yesc

2.05

3.9

9.73

3a

2

2

1

Yesc

0.02–0.23

5.2–5.7

9.36

4a

1

1

1

Yes

3.76

2.4

18.86

5a

3

3

3

Yesc

0.42–2.41

4.0–7.3

18.86

6

5

5

5

Yes

0.07–0.36

2.3–5.9

17.09

7a

4

4

4

Yes

0.17–0.73

2.9–4.5

22.09

8a

5

5

6b

Yesc

0.33–0.59

10.5–16.3

22.42

9a

2

2

1

Yesc

0.01–0.29

3.4–9.0

6.10

10

3

3

1

Yesc

0.01–4.18

4.0–9.2

6,67

11

4

4

3

Yesc

0.07–0.36

3.0–6.4

6.23

12

3

3

2

Yesc

0.21–1.52

2.4–8.0

5.97

13

2

2

1

Yes

0.29–0.79

4.6–5.9

5.0

14

4

4

4

Yesc

0.25–0.45

4.4–5.1

3.98

15

3

3

3

Yes

0.09–0.36

3.0–6.1

5.18

16

3

3

3

Yes

0.03–1.37

1.0–3.9

5.55

17

1

1

1

Yesc

0.03

6.1

5.42

18

2

2

2

Yesc

0.58–2.28

7.8–10.1

5.0

19

3

3

3

Yesc

0.05–3.84

4.0–7.8

5.85

20

1

1

2b

Yesc

0.01

3.6

4.86

aSome data from these pigs have been published previously: pigs 1–3 [14, 15], pigs 5–8 [16], and pigs 1–9 [40, 41]

bPigs 8 and 20 were diagnosed with osteomyelitis by necropsy and/or histology disclosing affection of the proximal and intermediary phalanges of toe no. IV in pig 8 and the intermediary and distal phalanges of toe no. V in pig 20; by scanning, only one of the lesions in each of the pigs was identified

cS. aureus identified by cultivation from a periosseous abscess (pigs 2, 3, 9–12, 14, 17–18), from an arthritic lesion (pig 8), from an inoculation site abscess (pig 19), and by immunohistochemistry (pigs 5 and 20)

Of the 56 OM lesions, 1 OM lesion developed in the right humoral bone and 55 OM lesions developed in the right hind limb. The OM lesions most often involved the growth zones of the long bones (Figs. 1 and 2). All lesions were recognized on CT (osteolysis, sequesters, fistulas, and cortical destructions (Figs. 2 and 3)). The lesion size ranged from 0.01 cm3 to 4.18 cm3, but all accumulated [18F]FDG PET (Table 1). The volume of 0.01cm3 seems to be about the limit for evaluation on CT, and the FDG-accumulation helped the interpretation. A small lesion of 0.07 cm3 seen on CT was examined histopathologically to confirm the existence of OM and the presence of coccoid bacteria (Fig. 2).
Fig. 2
Fig. 2

Above: Histopathology, a mid-sagittal section of distal right fibula of pig 11. Pathological subacute osteomyelitis in the cranial aspect of the bone located both distal (abscess) and proximal (suppuration with sequestration) to the growth plate. Sequester (S) and peripheral capsule (C). Bar 2 mm. Inset: bacteria and a necrotic bone trabecula. Bar 40 μm. HE stained. Below: A CT scan of the OM in the distal right fibula

Fig. 3
Fig. 3

A lesion in pig 6 with sequester formation marked by an arrow in the right proximal tibia (a). A lesion in pig 6 with both sequester and fistula formation marked by an arrow in the right calcaneus (b)

By reading the [18F]FDG PET/CT, 49 of the 56 OM lesions were identified as having formed sequesters and 44 had formed fistulas (Table 2). Four lesions formed neither sequesters nor fistulas 1 week after the inoculation with S. aureus (Table 2). In three cases of fistula formation, there were no signs of sequester formation on CT. The lesions were however very small (0.01 and 0.02 cm3).
Table 2

Numbers of osteomyelytic lesions among 56 lesions (20 pigs) with fistula and sequester formations judged by CT

OM with sequester

OM with fistula

OM with both sequesters and fistula

OM without neither sequesters nor fistulas

49

44

41

4

Maximal standardized uptake value (SUVmax) was higher in the group that formed sequester than in the group that did not, 5.2 versus 3.9 g/mL (p = 0.023), and SUVmax was also higher in the group that formed fistulous tracts than in the group that did not, 5.6 versus 3.3 g/mL (p < 0.0001). The volume of the OM lesion was similar whether the OM had formed fistulous tracts or not (p = 0.216), whereas sequester formation was more often seen in the larger OM lesions than in the smaller lesions (p < 0.0001). (SUVmax) was higher in OM with fistula formations than in OM with sequester formations, 4.7 g/mL versus 3.4 g/mL (p = 0.002).

The simulated variation of [18F]FDG activity (132 MBq, 44 MBq, 13.2 MBq, and 4.4 MBq) demonstrated that for 2 pigs, it was possible to reduce the activity of [18F]FDG to 4.4 MBq for both smaller and larger lesions, thereby reducing the dose of ionizing radiation. This corresponded to an injected activity as low as 0.19 MBq per kilogram BW. Examples of both a small and a large OM are shown in Figs. 4 and 5, respectively. The visual differences in the PET images were minimal although the simulation represents a 30-fold variation of the injected activity.
Fig. 4
Fig. 4

Above: CT scan (bone window) of a small (0.21 cm3) osteomyelytic lesion (osteolysis) in right proximal tibia of pig 13 (indicated by an arrow). Original SUVmax on Philips EBW was 2.4 g/mL. Below: Increasing activities of [18F]FDG in the osteomyelytic lesion of the right proximal tibia (indicated by arrows): 4.4 MBq (a), 13.2 MBq (b), 44 MBq (c), and 132 MBq (d) simulated injected activity

Fig. 5
Fig. 5

Above: CT scan (bone window) of the larger medial, irregular (1.52 cm3) osteomyelytic lesion in the right distal femur of pig 13 (indicated by an arrow). Original SUVmax on Philips EBW was 8.0 g/mL. Below: Increasing activities of [18F]FDG in the osteomyelytic lesion in the right distal femur (indicated by arrows): 4.4 MBq (a), 13.2 MBq (b), 44 MBq (c), and 132 MBq (d) simulated injected activity

Discussion

Although considered routine in adults, PET/CT in children has been somewhat limited. As in adults, unnecessary examinations should be avoided. Given a large number of [18F]FDG PET, and especially CT, examinations performed annually throughout the world, reduction of the administered activity without compromising the clinical information being sought is encouraged. The decision to utilize PET/CT in children should be made individually, taking cumulative radiation exposure and the benefit of the scan into account. For all nuclear medicine examinations, the optimum administered activity is a trade-off between radiation dose and the image SNR, which is defining the obtainable clinical sensitivity. The recommended maximum injected activity of [18F]FDG for paediatric use is in the range of 3.7 to 5.2 MBq/kg (0.10–0.14 mCi/kg), with a minimum injected activity of 26 MBq (0.7 mCi) [25]. We have demonstrated that in OM diagnostics, it is possible to reduce the injected activity of a radiotracer even more as our simulation study indicated that even small lesions are clearly visible at an injected activity as low as 0.19 MBq/kg BW (0.005 mCi/kg)). This supports the findings by Gatidis et al. in a PET/MRI study [26].

Many diagnostic tools are available, but no single test has 100% diagnostic accuracy [27]. It may have been easier for our imaging specialist to recognize even small OM lesions on CT scans since the time for interpretation of CT scans was unlimited, and we only examined juvenile animals that were otherwise healthy prior to inoculation. Children, in general, also suffer less from degenerative disorders in joints and bones than adults do, thus leading to the less competing glucose uptake in surrounding tissues which makes the interpretation of PET easier in children. Thus, we believe that our results in the pig model translate well, supporting the application of CT and reduced dosage of [18F]FDG in children to diagnose OM. By using the lower suggested activity of [18F]FDG for PET/CT, the radiation exposure in children will be lower than for [99mTc]MDP/HDP bone scan, which further speaks for using PET/CT.

Johansen and Jensen have reviewed the haematogenously spread S. aureus OM in animal models [20]. This group and others have noticed a similarity to children where OM most often involve the growth zones of the long bones of the lower extremities, perhaps due to more exposure of the long bones of the extremities to small blunt trauma from childhood activities, especially of boys, creating a locus of minor necrosis [28, 29]. Our studies show similar seeding of S. aureus in the growth zones of juvenile pigs as reported previously [14, 15]. This may be due to the characteristic blood supply in long bones of juveniles [10]. OM is most often localized to the lower limbs of children, and 50 % of cases occur in those less than 5 years of age, twice as frequent in males as in females [10]. This could support the argument for applying limited CT of the limbs in older children, which would reduce radiation exposure significantly. While OM typically is solitary, multifocal bone involvement occurs in 7% of children and in 22% of neonates [10]. In neonates, there may be a need for whole body examinations. It may be necessary to perform the scans with some degree of anaesthesia in some children, which could reinforce the idea of initiating the hunt for OM with the quicker CT.

The spatial resolution of our Siemens CT is about 1 mm and with PET about 4 mm. Since the concept of SUV is a normalization of the image voxel values to variation in injected activity and body weight, the apparent SUVmax is not expected to depend upon the tracer activity. However, obviously, the image noise level will increase when the activity is reduced (Poisson statistics). With the current generation of PET/CT scanners, 0.19 MBq/kg BW may thus be about the limit for the interpretation of FDG accumulation in OM.

Especially, small lesions in CT and PET images are affected by the partial volume effect (PVE) [3032]. The quantitative accuracy of PET images may thus be questionable as the spatial resolution is low (4–6 mm) compared to CT and MRI (< 1 mm) and the tissue sampling is limited. We have not made corrections for PVE as we compared with the normal anatomical site in the other limb when detecting OM lesions. The size of all OM lesions was measured on CT and thereby not affected by the limited spatial resolution of PET. To minimize PVE, we used SUVmax instead of the volumetric mean SUV. In clinics, the detection of an OM lesion is more important than the measurement of quantitative PET-tracer uptake. In recent years, a lot of effort has been put into the development of new CT scanners and scanning protocols that markedly reduce the absorbed dose without compromising the diagnostic performance and the image quality [3339]. In the pigs, the glucose metabolism was significantly higher in areas of fistula formation than in areas of sequester formation, indicating the attraction of cells with higher glucose metabolism in the former conditions. Probably, fistulation will reduce the intraosseous pressure in the cortical bones easing the perfusion, the inflammatory process, and the glucose uptake of reparative cells.

The elements normally considered to characterize chronic OM such as the presence of a sequestrum and/or a fistulous tract were very frequent and present as early as during the first week of infection in our pig study. Thus, the differentiation between acute and chronic OM in humans may be different in juvenile pigs indicating more aggressive pathogenesis in juvenile pigs, or that the progression of the disease in children may be faster than assumed.

To summarize, we believe that reduced dosage of [18F]FDG and limited bone localization CT may be useful in children in selected cases. It would be very interesting to examine these aspects in young children as the limitation of this study, obviously, was the use of an animal model. To accurately determine the optimum administered activity for paediatric OM protocols, however, a dedicated receiver operating characteristics (ROC) study in children will have to be performed.

Conclusions

In conclusion, [18F]FDG/CT helps to localize very small OM lesions in peripheral bones. This supports the use of PET/CT, also in children, as it was possible to reduce the injected activity markedly.

It would be interesting to see if the results obtained in our animal model will be relevant in clinical practice of imaging of the haematogenously spread S. aureus OM in peripheral bones, preferably in young children.

Abbreviations

BW: 

Body weight

CFU: 

Colony forming units

CT: 

Computed tomography

FDG: 

[18F]-fluorodeoxyglucose

HE: 

Haematoxylin-eosin

i.m.: 

Intramuscular

MRI: 

Magnetic resonance imaging

OM: 

Osteomyelitis

PET: 

Positron emission tomography

ROC: 

Receiver operating characteristics

S. aureus

Staphylococcus aureus

SNR: 

Signal to noise

SUVmax

Maximal standardized uptake value

Declarations

Acknowledgements

The work was supported by grant no. 0602-01911B (11-107077) from the Danish Council for Independent Research, Technology and Production Sciences.

Funding

The work was supported by grant no. 0602-01911B (11–107077) from the Danish Council for Independent Research, Technology and Production Sciences.

Availability of data and materials

Please contact the author for data requests.

Authors’ contributions

PA contributed to the idea, design, necropsy, analysis of imaging, interpretation of data, statistics, and writing of the manuscript. AKOA contributed to the treatment of living animals. OLN contributed to the histopathology and necropsy. SBH contributed to the modeling of the FDG data. HCS acquired the S. aureus and performed the microbiology. All authors have revised the manuscript critically for important intellectual content and given the final approval of the version to be published. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content and has agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Ethics approval and consent to participate

This is included in the manuscript as is also the approval by the Danish Animal Experimentation Board and by the Danish Occupational Health Surveillance.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Diagnostic Imaging, Section of Clinical Physiology and Nuclear Medicine, North Zealand Hospital, Dyrehavevej 29, 3400 Hillerod, Denmark
(2)
Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark
(3)
Department of Veterinary and Animal Science, University of Copenhagen, Copenhagen, Denmark
(4)
Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark
(5)
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
(6)
Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark

References

  1. Nickerson EK, Hongsuwan LD, Wuthiekanun W, Shaha KR, Srisomang P, Mahavanakul W, Wacharaprechasgul T, Fowler JG Jr, West TE, Teerawatanasuk N, Becher H, White NJ, Chierakul W, Day NP, Peacoc SJ. Staphylococcus aureus bacteremia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One. 2009;4:e4308.View ArticleGoogle Scholar
  2. Pääkkkönen M, Kallio PE, Kallio MJT, Peltola H. Management of osteoarticular infections caused by staphylococcus aureus is similar to that of other etiologies. The Pediatric Infectious Disease Journal. 2012;31:436–8.Google Scholar
  3. Van Schuppen J, van Doom MM, van Rijn RR. Childhood osteomyelitis: imaging characteristics. Insights Imaging. 2012;3:519–33.View ArticleGoogle Scholar
  4. Lew DP, Waledvogel FA. Osteomyelitis. Lancet. 2004;364:369–79.View ArticleGoogle Scholar
  5. Harris WH, Heaney RP. Skeletal renewal and metabolic bone disease. N Engl J Med. 1969;280:193–202.View ArticleGoogle Scholar
  6. Peltola H, Paakkonen M. Acute osteomyelitis in children. N Engl J Med. 2014;370:352–60.View ArticleGoogle Scholar
  7. Santiago Restrepo C, Gimenez CR, McCarthy K. Imaging of osteomyelitis and musculoskeletal soft tissue infections: current concepts. Rheum Dis Clin N Am. 2003;29:89–109.View ArticleGoogle Scholar
  8. Littenberg B, Mushlin AI. Technetium bone scanning in the diagnosis of osteomyelitis: a meta-analysis of test performance. Diagnostic Technology Assessment Consortium. J Gen Intern Med. 1992;7:158–64.View ArticleGoogle Scholar
  9. Van den Wyngaert T, Strobel K, Kampen WU, van der Kuwert Bruggen W, Mohan HK, Gnanasegaran G, Delgado-Bolton R, Weber WA, Beheshti M, Langsteger W, Giammarile F, Mottaghy FM, Paycha F, EANM Bone &Joint Committee and Oncology Committee. The EANM practice and guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43:1723–38.View ArticleGoogle Scholar
  10. Parisi MT, Otjen JP, Stanescu AL, Shulkin BL. Radionuclide imaging of infections and inflammation in children: a review. Semin Nucl Med. 2018;48:148–65.View ArticleGoogle Scholar
  11. Pineda C, Vargas A, RodriGuez AV. Imaging of osteomyelitis: current concepts. Infect Dis Clin N Am. 2006;20:789–825.View ArticleGoogle Scholar
  12. Jamar J, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A. EANM/SNMMI guide-line for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647–58.View ArticleGoogle Scholar
  13. Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TG, McGale P, Cain TM, Dowty JG, Bickerstaffe AC, Darby SC. Cancer risk in 680000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013;346:1–18.View ArticleGoogle Scholar
  14. Nielsen OL, Afzelius P, Bender D, Schønheyder HC, Leifsson PS, Nielsen KM, Larsen JO, Jensen SB, Alstrup AK. Comparison of autologous 111In-leukocytes, 18F-FDG, 11C-methionine, 11C-PK11195 and 68Ga-citrate for diagnostic nuclear imaging in a juvenile porcine haematogenous staphylococcus aureus osteomyelitis model. Am J Nucl Med Mol Imaging. 2015;5:169–82.PubMedPubMed CentralGoogle Scholar
  15. Afzelius P, Nielsen OL, Alstrup AKO, Bender D, Leifsson PS, Jensen SB, Schønheyder HC. Biodistribution of the radionuclides 18F-FDG, 11C-methionine, 11C-PK11195, and 68Ga-citrate in domestic juvenile female pigs and morphological and molecular imaging of the tracers in hematogenously disseminated Staphylococcus aureus lesions. Am J Nucl Med Mol Imaging. 2016;6:42–58.PubMedPubMed CentralGoogle Scholar
  16. Afzelius P, Alstrup AKO, Schønheyder HC, Borghammer P, Jensen SB, Bender D, Nielsen OL. Utility of 11C-methionine and 11C-donepezil for imaging of Staphylococcus aureus induced osteomyelitis in a juvenile porcine model: comparison to autologous 111In-labelled leukocytes, 99mTc-DPD, and 18F-FDG. Am J Nucl Med Mol Imaging. 2016;6:286–300.PubMedPubMed CentralGoogle Scholar
  17. Calhoun JH, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Semin Plast Surg. 2009;23:59–72.View ArticleGoogle Scholar
  18. Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am Fam Physician. 2001;63:2413–20.PubMedGoogle Scholar
  19. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86-A:2305–18.View ArticleGoogle Scholar
  20. Johansen LK, Jensen HE. Animal models of hematogenous Staphylococcus aureus osteomyelitis in long bones: a review. Orthop Res Rev. 2013;5:51–64.View ArticleGoogle Scholar
  21. Alstrup AK, Nielsen KM, Schønheyder HC, Jensen SB, Afzelius P, Leifsson PS, Nielsen OL. Refinement of a hematogenous localized osteomyelitis model in pigs. Scand J Lab Anim Sci. 2016;42:1–4.Google Scholar
  22. Alstrup AK, Winterdahl M. Imaging techniques in large animals. Scand J Lab Anim Sci. 2009;36:55–66.Google Scholar
  23. Aalbæk B, Jensen LK, Jensen HE, Olsen JE, Christensen H. Whole-genome sequence of Staphylococcus aureus S54F9 isolated from a chronic disseminated porcine lung abscess and used in human infection models. Genome Announc. 2015;3:e01207–15.View ArticleGoogle Scholar
  24. Jensen HE, Nielsen O, Agerholm JS, Iburg T, Johansen LK, Johannesson E, Møller M, Jahn L, Munk L, Aalbæk B, Leifsson PS. A non-traumatic Staphylococcus aureus osteomyelitis model in pigs. In vivo. 2010;24:257–64.PubMedGoogle Scholar
  25. Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med. 2011;52:318–22.View ArticleGoogle Scholar
  26. Gatidis S, Schmidt H, la Fougere C, Nikolaou K, Schwenzer NF, Schäfer JF. Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI. Eur J Nucl Med Mol Imaging. 2016;43:2283–9.View ArticleGoogle Scholar
  27. Signore A, Glaudemans AWJM, Gheysens O, Lauri C, Catalano OA. Nuclear medicine imaging in pediatric infection or chronic inflammatory diseases. Semin Nucl Med. 2017;47:286–303.View ArticleGoogle Scholar
  28. Johansen LK, Koch J, Kirketerp-Møller K, Wamsler OJ, Nielsen OL, Leifsson PS, Frees D, Aalbæk B, Jensen HB. Therapy of haematogenous osteomyelitis-a comparative study in a porcine model and Angolan children. In Vivo. 2013;27:305–12.PubMedGoogle Scholar
  29. Dartnell J, Ramachandran N, Kartcuburian M. Haematogeneous acute and subacute paediatric osteomyelitis: a systemic review of the literature. J Bone Joint Surg Br. 2012;94:584–95.View ArticleGoogle Scholar
  30. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.View ArticleGoogle Scholar
  31. Bettinardi V, Castiglioni I, DeBernardi E, Gilardi MC. PET quantification: strategies for partial volume correction. Clinical and Translational Imaging. 2014;2:199–218.View ArticleGoogle Scholar
  32. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. effect of object size. J Comput Assist Tomogr. 1979;3:299–308.View ArticleGoogle Scholar
  33. Padole A, Khawaja RDA, Kalra MK, Singh S. CT radiation dose and iterative reconstruction techniques. AJR. 2015;204:W384–92.View ArticleGoogle Scholar
  34. Den Harder AM, Willemink MJ, De Ruiter QMB, De Jong PA, Schilham AM, Krestin GP, Leiner T, Budde RP. Dose reduction with iterative reconstruction for coronary CT angiography: a systematic review and meta-analysis. Br J Radiol. 2016;89:20150068.View ArticleGoogle Scholar
  35. Leipsic JL, Heilbron BG, Hague C. Iterative reconstruction for coronary CT angiography: finding its way. Int J Cardiovasc Imaging. 2012;28:613–20.View ArticleGoogle Scholar
  36. Den Harder AM, Willemink MJ, De Ruiter QMB, Schilham AM, Krestin GP, Leiner T, de Jong PA, Budde RP. Achievable dose reduction using iterative reconstruction for chest computed tomography: a systematic review. Eur J Radiol. 2015;84:2307–13.View ArticleGoogle Scholar
  37. Liu HL. Model-based iterative reconstruction: a promising algorithm for today’s computed tomography imaging. J Med Imaging and Radiation Sciences. 2014;45:131–6.View ArticleGoogle Scholar
  38. Gatewood MO, Grubish L, Busey JM, Shuman WP, Strote J. The use of model-based iterative reconstruction to decrease ED radiation exposure. Am J Emerg Med. 2015;33:559–62.View ArticleGoogle Scholar
  39. Klink T, Obmann V, Heverhagen J, Stork A, Adam G, Begemann P. Reducing CT radiation dose with iterative reconstruction algorithms: the influence of scan and reconstruction parameters on image quality and CTDIvol. Eur J Radiol. 2014;83:1645–54.View ArticleGoogle Scholar
  40. Jødal L, Nielsen OL, Afzelius P, Alstrup AKO, Hansen SB. Blood perfusion in osteomyelitis studied with [15O]water PET in a juvenile porcine model. Eur J Nucl Med Mol Imag Res. 2017;7:1–10.Google Scholar
  41. Jødal L, Jensen SB, Nielsen OL, Afzelius P, Borghammer P, Alstrup AKO, Hansen SB. Kinetic modelling of infection tracers [18F]FDG, [68Ga]Ga-citrate, [11C]methionine and [11C]donepezil in a porcine osteomyelitis model. Contrast Media & Molecular Imaging. 2017; https://doi.org/10.1155/2017/9256858.

Copyright

© The Author(s). 2019

Advertisement